MedTrace Logo

Benin Population Diversity of Tuberculosis and Implications

NCT02744469 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1490

Last updated 2021-02-23

No results posted yet for this study

Summary

Tuberculosis is a public health problem caused by a microbe. This microbe may differ from one patient to another. The purpose of this study is to know to which extent, each of these various microbes is involved in tuberculosis disease in Benin. This study will also find out whether the type that affects a patient, depends on patient characteristics and whether the difference affects the outcome of the treatment. Finally the study will also help to find out whether diagnostic tests are reliable for all types of the microbe. This information will be used after the study to inform decision making in order to improve tuberculosis control.

Conditions

Interventions

OTHER

No intervention (observational study)

Sponsors & Collaborators

  • Direction Générale de la Coopération au Développement, Belgique

    collaborator UNKNOWN

  • Institute of Tropical Medicine, Belgium

    collaborator OTHER

  • Universiteit Antwerpen

    collaborator OTHER

  • Laboratoire de Référence des Mycobactéries, Benin republic

    collaborator UNKNOWN

  • Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou, Benin

    collaborator UNKNOWN

  • Centres de Diagnostic et de Traitement de la tuberculose, National Tuberculosis Programme, Benin

    collaborator UNKNOWN

  • Laboratoire de Référence des Mycobactéries

    lead OTHER_GOV

Principal Investigators

  • Dissou Affolabi, MD PhD Prof · Laboratoire de Référence des Mycobactéries, Benin

  • Bouke de Jong, MD PhD Prof · Institute of Tropical Medicine, Belgium

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-12
Primary Completion
2018-01-08
Completion
2019-12-12

Countries

  • Belgium
  • Benin

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02744469 on ClinicalTrials.gov